Bookmark

Add to MyYahoo RSS

Arena Pharmaceuticals News

News on Arena Pharmaceuticals (Ticker: ARNA) continually updated from thousands of sources around the net.

Friday Aug 29 | Seeking Alpha

Belviq Sales Crack Critical Level

Sales of the anti-obesity Drug Belviq from Arena Pharmaceuticals passed a critical level today with an improvement of 3.4% over the numbers last week.

Comment?

Related Topix: Biotech, Drugs, Medicine, Healthcare Industry, Arena Pharmaceuticals, Startups, VIVUS

Mon Aug 25, 2014

Seeking Alpha

Belviq Sales Rise 2%

Sales of the anti-obesity pill Belviq from Arena Pharmaceuticals continued to buck the seasonality factor by bringing in a 2% increase in week over week sales according to industry tracker IMS Health.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing, Sales, TV Advertising, Startups, VIVUS

BioSpace

Biotech Hiring Surge: Trends To Watch; Industry Tips from Arena Pharmaceuticals, Inc.

August 25, 2014 By Josh Baxt , BioSpace.com Exclusive Story Everyone remembers the bad old days of 2009.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Startups, BioSpace.com

Fri Aug 15, 2014

Seeking Alpha

FDA Data: Good News For One Anti-Obesity Company, Not So Good For Another

The FDA Adverse Events raw data for Q4 of 2013 have been released, and while the exact information relating to the nature of adverse events will take some time to make its way to the public, it is possible to search through the raw data to see the number of times that a particular drug comes up within the data.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Startups, VIVUS

Wed Aug 13, 2014

Seeking Alpha

A Deeper Look At MannKind - Sanofi Deal And Valuation

The excitement of the new deal between MannKind and Sanofi has now been absorbed, and the street is now assessing how it feels the deal will impact MannKind.

Comment?

Related Topix: Biotech, MannKind, Medicine, Healthcare Industry, Arena Pharmaceuticals

AmericanBankingNews.com

Arena Pharmaceuticals Short Interest Down 2.2% in July

Shares of Arena Pharmaceuticals were the recipient of a significant decrease in short interest during the month of July.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Mon Aug 11, 2014

Sys-Con Media

Post-Earnings Review and Highlights - Arena Pharma

Investor-Edge.com has issued complimentary earnings coverage on Arena Pharmaceuticals Inc. as the company featured in the headlines on, per diluted share decline in net income per share in the second quarter of 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing

Fri Aug 08, 2014

Seeking Alpha

Arena's Belviq Bucks Seasonality With 3.6% Week Over Week Gain

Sales of the anti-obesity pill Belviq from Arena Pharmaceuticals continue to buck the seasonality of the weight loss sector with a 3.6% week over week gain.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Thu Aug 07, 2014

AmericanBankingNews.com

Arena Pharmaceuticals Receives Consensus Rating of "Hold" from Brokerages

Shares of Arena Pharmaceuticals have earned a consensus rating of "Hold" from the eight ratings firms that are currently covering the stock, Analyst Ratings News reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Mon Aug 04, 2014

Seeking Alpha

One-Time Stock Sale Boosts Arena To Profit

Arena Pharmaceuticals beat the street by an impressive $0.14 per share. Some investors were thrilled with the news, but more experienced investors saw the quarter for what it was and removed the one-time event to look at this quarter from a business perspective.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••